Alienation and Authenticity in Parkinson's Disease and Its Treatment

Author： Mosley Philip E. Hall Wayne Forlini Cynthia Carter Adrian

ISSN： 2150-7740

Source： AJOB Neuroscience, Vol.5, Iss.4, 2014-10, pp. : 54-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Selegiline in the treatment of Parkinson's disease: its impact on orthostatic hypotension

By Bhattacharya K.F. Nouri S. Olanow C.W. Yahr M.D. Kaufmann H.

Parkinsonism and Related Disorders, Vol. 9, Iss. 4, 2003-03 ,pp. : 221-224

Elsevier

Access to resources Recommend Favorite

Parkinson's Disease: The Treatment Options.

By Bain P.G.

Brain, Vol. 123, Iss. 3, 2000-03 ,pp. : 651-652

Oxford University Press

Access to resources Recommend Favorite

Neural transplantation for the treatment of Parkinson's disease

By Bjorklund A. Dunnett S.B. Brundin P. Stoessl A.J. Freed C.R. Breeze R.E. Levivier M. Peschanski M. Studer L. Barker R.

Lancet Neurology, Vol. 2, Iss. 7, 2003-07 ,pp. : 437-445

Elsevier

Access to resources Recommend Favorite

The potential of GDNF as a treatment for Parkinson's disease

By Hurelbrink C.B. Barker R.A.

Experimental Neurology, Vol. 185, Iss. 1, 2004-01 ,pp. : 1-6

Elsevier

Access to resources Recommend Favorite

New treatment of depression in Parkinson's disease

By Maruyama Tetsuhiro

International Journal of Psychiatry in Clinical Practice, Vol. 7, Iss. 1, 2003-01 ,pp. : 25-27

Ashgate Publishing Ltd

Access to resources Recommend Favorite